OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Top 3 AI Stocks to Invest in Right Now

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds • News

Dow Jones Newswires: AstraZeneca’s Forxiga gets EU approval recommendation for symptomatic chronic heart failure

December 19, 2022

The recommendation covers heart failure with reduced ejection fraction--a measure of the amount of blood the heart's left ventricle pumps with each heartbeat...

3rdPartyFeeds • News

Dow Jones Newswires: AstraZeneca’s Imfinzi plus Imjudo recommended for approval in the EU

December 19, 2022

The Anglo-Swedish pharma giant said the Committee for Medicinal Products for Human Use of the European Medicines Agency based its opinion on results from the...

3rdPartyFeeds

TV and movie streaming: how UK viewers can save

December 19, 2022

How to cut costs on viewing services such as Netflix, Disney+ and Amazon Prime Video Read More...

3rdPartyFeeds

Microsoft President Brad Smith navigates familiar antitrust territory

December 19, 2022

Smith spent the last year defending a major acquisition in the court of public opinion. Now he's ready to fight the Microsoft's case in the court of law. Read...

3rdPartyFeeds

Microsoft president Brad Smith: Navigating familiar anti-trust territory

December 19, 2022

Microsoft President Brad Smith spent the last year defending a major acquisition in the court of public opinion. Now he's ready to fight the company's case in...

3rdPartyFeeds

Big Techs’ Growing Finance Business Is Getting Them Bank-Like Treatment. Are Beaten Down Tech Stocks A Buy Now?

December 18, 2022

Tech stocks are trading below their 50-day moving average. Watch these support and resistance levels on your tech watchlist. Read More...

3rdPartyFeeds • News

: Elon Musk says he’ll quit if poll tells him to, as Twitter reverses ban on accounts that promote other social networks

December 18, 2022

Twitter early Sunday announced it would ban accounts that post links or usernames for certain "prohibited" third-party social media platforms, only to...

3rdPartyFeeds

Dow Jones Futures Rise After Stock Market Rally’s Ugly Outside Week; Here’s What To Do

December 18, 2022

The market rally started strong, but sold off hard in a big outside week. Apple, Tesla dived. Leading stocks tumbled. Here's what to do. Read More...

3rdPartyFeeds • News

Dow Jones Newswires: Toshiba shares slump after reported cut in buyout valuation

December 18, 2022

Toshiba Corp. shares fell sharply Monday morning following a report that a group led by Japan Industrial Partners Inc. may cut the valuation for a possible...

3rdPartyFeeds • News

The Wall Street Journal: L3Harris plans to buy rival defense contractor Aerojet for $4.7 billion

December 18, 2022

Defense firm L3Harris Technologies Inc. on Sunday said it agreed to buy Aerojet Rocketdyne Holdings Inc. in a $4.7 billion deal that would cement L3Harris’s...

Previous 1 … 1,897 1,898 1,899 1,900 1,901 … 8,455 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.